Campbell introduces Encuity venture

Share this article:

Biopharma consultancy Campbell Alliance launched a market research and analytics group, one that could pose a threat to traditional MR firms.

The subsidiary, called Encuity Research, will be led by Campbell veteran Michael Turner.

It combines three components: SDI Health promotional and medical audit businesses that the consulting firm's parent, inVentiv Health, bought from IMS Health; service lines that came to Campbell after it was bought by inVentiv in 2011—RapidRecall (message effectiveness), Metropolitan Area Promotional Audit (syndicated audits of promotional activity), VisionCare (contact-lens market data), as well as a custom KOL mapping service; and Campbell's custom MR capability to support consulting projects.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: Ipsen head leads continental charge

Headliner: Ipsen head leads continental charge

"When I look at the business, I actually see patients in my mind. I don't see numbers."

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets